JANUS HENDERSON GROUP PLC

Holdings History for Protagonist Therapeutics, Inc - Common Stock, $0.00001 par value (PTGX)

Symbol: PTGX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.1%	+0.06%	$231,354,837	2,649,981	+1,549,160	+141%	$87.30	Q4 2025
30 Sep 2025	0.03%	+0.02%	$73,165,449	1,100,821	+653,993	+146%	$66.46	Q3 2025
30 Jun 2025	0.01%	+0.01%	$24,702,654	446,828	+425,374	+1983%	$55.28	Q2 2025
31 Mar 2025	0%	0%	$1,048,457	21,454	0		$48.87	Q1 2025
31 Dec 2024	0%	0%	$827,803	21,454	0		$38.59	Q4 2024
30 Sep 2024	0%	0%	$965,001	21,454	0		$44.98	Q3 2024
30 Jun 2024	0%	-0%	$742,952	21,454	-281	-1.3%	$34.63	Q2 2024
31 Mar 2024	0%	0%	$628,042	21,735	+1	+0%	$28.90	Q1 2024
31 Dec 2023	0%	-0%	$498,575	21,734	-41	-0.19%	$22.94	Q4 2023
30 Sep 2023	0%	0%	$363,529	21,775	+20	+0.09%	$16.69	Q3 2023
30 Jun 2023	0%	+0%	$600,552	21,755	+4,505	+26%	$27.61	Q2 2023
31 Mar 2023	0%	+0%	$397,004	17,250	+17,250	NEW	$23.01	Q1 2023
31 Mar 2022		-0%	$0	0	-8,014	-100%	$81.93	Q1 2022
31 Dec 2021	0%	+0%	$274,000	8,014	+8,014	NEW	$34.19	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.